Cargando…

Epigenetics studies of fetal alcohol spectrum disorder: where are we now?

Adverse in utero events can alter the development and function of numerous physiological systems, giving rise to lasting neurodevelopmental deficits. In particular, data have shown that prenatal alcohol exposure can reprogram neurobiological systems, altering developmental trajectories and resulting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lussier, Alexandre A, Weinberg, Joanne, Kobor, Michael S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2017
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549650/ https://www.ncbi.nlm.nih.gov/pubmed/28234026 http://dx.doi.org/10.2217/epi-2016-0163

Ejemplares similares

Focus On: Epigenetics and Fetal Alcohol Spectrum Disorders
por: Kobor, Michael S., et al.
Publicado: (2011)

Intersection of Epigenetic and Immune Alterations: Implications for Fetal Alcohol Spectrum Disorder and Mental Health
por: Lussier, Alexandre A., et al.
Publicado: (2021)

DNA methylation as a predictor of fetal alcohol spectrum disorder
por: Lussier, Alexandre A., et al.
Publicado: (2018)

Deep Brain Stimulation for Addictive Disorders—Where Are We Now?
por: Yuen, Jason, et al.
Publicado: (2022)

MHC Restriction: Where Are We Now?
por: Zareie, Pirooz, et al.
Publicado: (2020)

FDG-PET/CT in Lymphoma: Where Do We Go Now?
por: Al Tabaa, Yassine, et al.
Publicado: (2021)

Toward a genome sequence for every animal: Where are we now?
por: Hotaling, Scott, et al.
Publicado: (2021)

MR-Guided Focused Ultrasound for Refractory Epilepsy: Where Are We Now?
por: Labate, Angelo, et al.
Publicado: (2023)

Bisphenol A: Where to Now?
por: Bucher, John R.
Publicado: (2009)

Prenatal Adversity Alters the Epigenetic Profile of the Prefrontal Cortex: Sexually Dimorphic Effects of Prenatal Alcohol Exposure and Food-Related Stress
por: Lussier, Alexandre A., et al.
Publicado: (2021)

Alcohol care teams: where are we now?
por: Moriarty, Kieran John
Publicado: (2019)

Dietary Supplement for Core Symptoms of Autism Spectrum Disorder: Where Are We Now and Where Should We Go?
por: Li, Yong-Jiang, et al.
Publicado: (2017)

Fetal alcohol spectrum disorder: molecular insights into neural damage reduction
por: Le Duc, Diana
Publicado: (2015)

DNA methylation signature of human fetal alcohol spectrum disorder
por: Portales-Casamar, Elodie, et al.
Publicado: (2016)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Prenatal alcohol exposure alters gene expression in the rat brain: Experimental design and bioinformatic analysis of microarray data
por: Lussier, Alexandre A., et al.
Publicado: (2015)

Mathematics anxiety—where are we and where shall we go?
por: Cipora, Krzysztof, et al.
Publicado: (2022)

Genetic and epigenetic insights into fetal alcohol spectrum disorders
por: Ramsay, Michèle
Publicado: (2010)

Editorial: Genetics and epigenetics of fetal alcohol spectrum disorders
por: Mason, Stephen, et al.
Publicado: (2015)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going to
por: Carofiglio, Francesca, et al.
Publicado: (2020)

Animal Models of Neurological Disorders: Where Are We Now?
por: Panthi, Sandesh, et al.
Publicado: (2023)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Natural Products and Synthetic Biology: Where We Are and Where We Need To Go
por: Kunakom, Sylvia, et al.
Publicado: (2019)

Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Breast Implant Surfaces and Their Impact on Current Practices: Where We Are Now and Where Are We Going?
por: Munhoz, Alexandre Mendonça, et al.
Publicado: (2019)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Lymph Node Ultrasound in Lymphoproliferative Disorders: Where Are We Now?
por: Tavarozzi, Rita, et al.
Publicado: (2021)

Calcaneal fractures: Where are we now?
por: Razik, Aisha, et al.
Publicado: (2017)

Intracranial Atherosclerosis: Where Are We Now?
por: Kim, Jong S.
Publicado: (2017)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_13c4hmjb871q7macrrpnq581vg